Marsh & McLennan Companies, Inc. (MRSH) fair value analysis
S&P 500 · Updated 2026-10-19
MRSH price how computed
Valuation status
No fair-value estimate yetMRSH has no usable analyst consensus for next fiscal year's earnings, or too few reported quarters for our trailing P/E history.
Forward Fair Value needs both, so TickrTrends publishes no verdict for MRSH yet. We re-check every week; the price, fundamentals, technicals and earnings data below are unaffected.
- Last price
- $188.35
- Sector
- Financial Services
- 12-month range
- $157.32–$197.59
- Market cap
- $89.9B
- From 52-week high
- -4.7%
- Shares outstanding
- 477M
- Rank in Financial Services by quality score
- #141 of 207
Last price is the 2026-10-16 close; the chart runs through 2026-10-16.
Marsh & McLennan Companies, Inc. is a global professional services firm that provides insurance brokerage, risk management, and consulting services to clients across various industries. The company operates in multiple countries worldwide, serving businesses, institutions, and individuals through its network of offices and subsidiaries.
MRSH currently ranks #141 of 207 Financial Services stocks by quality score.
Fundamentals (4 quarters) how computed
- Market cap
- $89.9B
- P/E (trailing)
- 18x
- Revenue (TTM)
- $28.5B
- Net margin
- 14.2%
- EPS (TTM)
- $10.40
- Gross margin
- 40.6%
- Debt / equity
- 1.52
- Revenue growth (3-yr avg)
- 7.9%
- Shares outstanding
- 477M
Derived indicators how computed
- Quality grade
- D
- Margin trend
- Stable
- 52-week position
- The top quarter of its range
Technicals how computed
- RSI (14-day)
- 76 · overbought
- 50-day average
- $181.28
- 200-day average
- $176.70
- Moving-average state
- 50-day above 200-day (golden cross state); price above both averages
Dividends how computed
- Paid, last 12 months
- $3.78 per share (4 payments)
- Yield on last price
- 2.01%
- Consecutive years of increases
- 16
- Last ex-dividend date
- 2026-10-01
- Last payment date
- 2026-11-13
Earnings how computed
- Last 8 quarters vs consensus
- 8 beat, 0 missed
- Quarter by quarter
- 2026-09 ▲ beat (+3.6%)
2026-06 ▲ beat (+2.8%)
2026-03 ▲ beat (+2.2%)
2025-12 ▲ beat (+7.6%)
2025-09 ▲ beat (+3.9%)
2025-06 ▲ beat (+2.3%)
2025-03 ▲ beat (+2.0%)
2024-12 ▲ beat (+6.3%)
Analyst consensus how computed
This is not TickrTrends' verdict.
- Analyst ratings
- 7 buy · 15 hold · 1 sell (23 analysts)
- Consensus lean
- Hold-leaning
- Consensus price target
- $205
- Target vs last price
- +8.8%
What our data shows for MRSH
- Shares are trading in the upper third of their 12-month price range of $157.32–$197.59.
- The 14-day relative strength index sits at an overbought 76.
What subscribers see
- Every published Forward Fair Value with its exact discount or premium
- The normalized P/E and quarter count behind each estimate
- Screeners and rankings across the full S&P 500 and Nasdaq universes
- MRSH's own verdict the week it qualifies, published automatically
Forward Fair Value applies a conservatively normalized historical price-to-earnings multiple to the consensus earnings estimate for the next full fiscal year; how TickrTrends computes it.
What people are saying
Follow the MRSH conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-10-19 — TickrTrends' derived indicators for MRSH show several notable shifts this week. The balance-sheet leverage band moved from moderate to high, the quality grade declined from C to D, and the revenue growth band contracted from strong to modest, while the RSI zone transitioned from neutral to overbought. The current valuation verdict for this Financial Services sector company remains awaiting full valuation.
- 2026-10-12 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-11 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-10 — TickrTrends' derived indicators for MRSH showed a shift this week as the Relative Strength Index moved from oversold into neutral territory. The company operates in the Financial Services sector and currently awaits a full valuation assessment. This change in the RSI zone suggests a technical positioning shift in the stock's recent trading patterns.
- 2026-10-06 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-05 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-28 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.
Frequently asked questions
Is MRSH stock undervalued?
TickrTrends has no fair-value estimate for MRSH yet: there is no usable analyst consensus for next fiscal year's earnings, or too few reported quarters for a trailing P/E history. It is re-checked every week.
What is MRSH's TickrTrends verdict?
MRSH is currently marked 'No fair-value estimate yet' - a verdict publishes automatically once a forward earnings consensus and enough reported quarters are available.
How does MRSH compare to other Financial Services stocks?
MRSH ranks #141 of 207 Financial Services stocks in TickrTrends' coverage by quality score. It carries no fair-value verdict yet, so it is not ranked by discount.
Is MRSH overbought or oversold?
MRSH's 14-day RSI is in the overbought zone on TickrTrends' latest weekly data.
Does MRSH pay a dividend?
Yes. MRSH paid $3.78 per share over the last twelve months (4 payments), a 2.01% yield on TickrTrends' last price, and has raised the annual total for 16 consecutive years. The last ex-dividend date was 2026-10-01.
Does MRSH usually beat earnings estimates?
Over its last 8 reported quarters MRSH beat the consensus estimate 8 times and missed 0 times, by TickrTrends' comparison of reported and estimated EPS.
What do analysts say about MRSH?
Of 23 analysts covering MRSH, 7 rate it a buy, 15 a hold and 1 a sell - hold-leaning, with a consensus price target of $205 (+8.8% versus TickrTrends' last price). This is the analyst consensus, not TickrTrends' Forward Fair Value verdict.